Effect of age on fructose malabsorption in children presenting with gastrointestinal symptoms

Hilary F Jones1, Esther Burt, Kate Dowling

  • 1Cell Biology of Disease Research Group and PERI Centre, Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia.

Insights

Children under 10 absorb fructose poorly, leading to more positive fructose malabsorption breath hydrogen tests (BHTs). This absorption capacity improves with age, unlike lactose malabsorption BHT results.

Area of Science:

  • Gastroenterology
  • Pediatric Gastroenterology
  • Clinical Diagnostics

Background:

  • Fructose malabsorption is a common cause of chronic diarrhea and abdominal pain.
  • Breath hydrogen testing (BHT) is used to diagnose carbohydrate malabsorption.
  • The impact of patient age on BHT results for fructose and lactose malabsorption requires clarification.

Purpose of the Study:

  • To investigate the effect of patient age on the clinical application of the fructose breath hydrogen test (BHT).
  • To compare the age-related performance of the fructose BHT with the lactose BHT.

Main Methods:

  • Retrospective review of BHT results from a gastroenterology clinic (2003-2008).
  • Patients underwent BHT after consuming either fructose (0.5 g/kg, max 10 g) or lactose (2 g/kg, max 20 g).
  • Test results were analyzed for correlations with patient age.

Main Results:

  • Age significantly affected fructose BHT results (P < 0.001) in 1093 patients.
  • Positive fructose malabsorption rates decreased with age: 88.2% (<1 yr), 66.6% (1-5 yrs), 40.4% (6-10 yrs), 27.1% (10-15 yrs).
  • No significant age-related effect was observed for lactose BHT results (P = 0.115) in 3073 patients.

Conclusions:

  • Infants and young children exhibit a lower threshold for fructose absorption, with capacity increasing up to age 10.
  • Age-specific interpretation of fructose BHT results is crucial for accurate diagnosis in pediatric patients.
  • Dietary recommendations for fructose intake in infants with gastrointestinal symptoms should consider age-related absorption capacity.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...